Jim O’Neill, a Silicon Valley investor and nominee for deputy HHS secretary, discussed AI applications during a Senate Finance Committee confirmation hearing, but not his controversial statements about FDA approval standards.
O’Neill said AI could improve the accuracy and speed of research and allow for quicker Medicare and Medicaid reimbursement decisions.
The hearing fell shortly before the FDA announced AI use in application reviews would be expanded from pilot stage to all centers by the end of June.

US HHS Deputy Nominee Talks AI, Not FDA, In Confirmation Hearing

More from AI